Baebies Overview
- Status
-
Private
- Employees
-
71
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.05M
- Investors
-
37
Baebies General Information
Description
Provider of a screening and pediatric testing technology intended to save the lives of newborns. The company's technology operates on digital microfluidics, which maximizes diagnostic yield from low-volume samples, and one drop of blood is used to quantitatively measure the activity of lysosomal enzymes from newborn dried blood spot specimens, enabling patients with early disease detection and multifunctional diagnostics for syndromic testing for children and adults.
Contact Information
Website
www.baebies.comCorporate Office
- Research Triangle Park
- Durham, NC 27703
- United States
Corporate Office
- Research Triangle Park
- Durham, NC 27703
- United States
Baebies Timeline
Baebies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 34. Later Stage VC | 22-Sep-2025 | $2.05M | Completed | Generating Revenue | ||
| 33. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 32. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 31. Grant | 08-Jun-2023 | Completed | Generating Revenue | |||
| 30. Grant | 23-May-2022 | Completed | Generating Revenue | |||
| 29. Later Stage VC (Series C) | 03-May-2022 | Completed | Generating Revenue | |||
| 28. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 27. Grant | 21-Sep-2021 | Completed | Generating Revenue | |||
| 26. Later Stage VC (Series B) | 25-May-2021 | $28.3M | $37.6M | Completed | Generating Revenue | |
| 25. Grant | 19-May-2021 | $2.7M | $9.4M | Completed | Generating Revenue |
Baebies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A1 | ||||||||
| Series A | 16,250,000 | $0.000100 | $0.8 | $0.8 | 1x | $0.8 | 32.5% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Baebies Comparisons
Industry
Financing
Details
Baebies Competitors (9)
One of Baebies’s 9 competitors is Natus Medical, a Private Equity-Backed company based in Middleton, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Natus Medical | Private Equity-Backed | Middleton, WI | ||||
| Cepheid | Formerly VC-backed | Sunnyvale, CA | ||||
| QuantuMDx | Venture Capital-Backed | Newcastle Upon Tyne, United Kingdom | ||||
| Abionic | Venture Capital-Backed | Lausanne, Switzerland | ||||
| ELITechGroup | Formerly PE-Backed | Puteaux, France |
Baebies Patents
Baebies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025106588-A1 | Host response assays for a point-of-care (poc) platform and methods | Inactive | 13-Nov-2023 | ||
| EP-4805725-A1 | Devices and systems for the detection of analytes and methods of using the same | Pending | 10-Nov-2023 | ||
| WO-2025102074-A1 | Devices and systems for the detection of analytes and methods of using the same | Inactive | 10-Nov-2023 | ||
| EP-4630164-A1 | Methods for performing rapid polymerase chain reaction (pcr) protocols in microfluidics system | Pending | 08-Dec-2022 | ||
| WO-2024124087-A1 | Methods for performing rapid polymerase chain reaction (pcr) protocols in microfluidics system | Inactive | 08-Dec-2022 | B01L3/502792 |
Baebies Signals
Baebies Investors (37)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| BOE Technology Group | Corporation | Minority | ||
| Angel (individual) | Minority | |||
| CureDuchenne Ventures | Corporate Venture Capital | Minority | ||
| Angel (individual) | Minority |
Baebies FAQs
-
Where is Baebies headquartered?
Baebies is headquartered in Durham, NC.
-
What is the size of Baebies?
Baebies has 71 total employees.
-
What industry is Baebies in?
Baebies’s primary industry is Diagnostic Equipment.
-
Is Baebies a private or public company?
Baebies is a Private company.
-
What is Baebies’s current revenue?
The current revenue for Baebies is .
-
How much funding has Baebies raised over time?
Baebies has raised $51.6M.
-
Who are Baebies’s investors?
, BOE Technology Group, , CureDuchenne Ventures, and are 5 of 37 investors who have invested in Baebies.
-
Who are Baebies’s competitors?
Natus Medical, Cepheid, QuantuMDx, Abionic, and ELITechGroup are some of the 9 competitors of Baebies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process